Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Salt-sensitive hypertension is associated with dysfunctional Cyp4a10 gene and kidney epithelial sodium channel
Kiyoshi Nakagawa, … , Michael R. Waterman, Jorge H. Capdevila
Kiyoshi Nakagawa, … , Michael R. Waterman, Jorge H. Capdevila
Published June 1, 2006
Citation Information: J Clin Invest. 2006;116(6):1696-1702. https://doi.org/10.1172/JCI27546.
View: Text | PDF
Research Article Cardiology Article has an altmetric score of 7

Salt-sensitive hypertension is associated with dysfunctional Cyp4a10 gene and kidney epithelial sodium channel

  • Text
  • PDF
Abstract

Functional and biochemical data have suggested a role for the cytochrome P450 arachidonate monooxygenases in the pathophysiology of hypertension, a leading cause of cardiovascular, cerebral, and renal morbidity and mortality. We show here that disruption of the murine cytochrome P450, family 4, subfamily a, polypeptide 10 (Cyp4a10) gene causes a type of hypertension that is, like most human hypertension, dietary salt sensitive. Cyp4a10–/– mice fed low-salt diets were normotensive but became hypertensive when fed normal or high-salt diets. Hypertensive Cyp4a10–/– mice had a dysfunctional kidney epithelial sodium channel and became normotensive when administered amiloride, a selective inhibitor of this sodium channel. These studies (a) establish a physiological role for the arachidonate monooxygenases in renal sodium reabsorption and blood pressure regulation, (b) demonstrate that a dysfunctional Cyp4a10 gene causes alterations in the gating activity of the kidney epithelial sodium channel, and (c) identify a conceptually novel approach for studies of the molecular basis of human hypertension. It is expected that these results could lead to new strategies for the early diagnosis and clinical management of this devastating disease.

Authors

Kiyoshi Nakagawa, Vijaykumar R. Holla, Yuan Wei, Wen-Hui Wang, Arnaldo Gatica, Shouzou Wei, Shaojun Mei, Crystal M. Miller, Dae Ryong Cha, Edward Price, Roy Zent, Ambra Pozzi, Matthew D. Breyer, Youfei Guan, John R. Falck, Michael R. Waterman, Jorge H. Capdevila

×

Figure 2

Amiloride normalizes the blood pressure of hypertensive Cyp4a10–/– mice.

Options: View larger image (or click on image) Download as PowerPoint

                  Amiloride normalizes the blood pressure of hypertensi...
The systolic blood pressure of male Cyp4a10–/– (discontinuous line) and Cyp4a10+/+ (continuous line) mice (n = 5 each) on diets containing 0.3% NaCl (w/w) were monitored before (days 1 to 4) and after the sequential administration of drinking water containing amiloride (days 8 to 21), a mixture of amiloride and 2% NaCl (days 22 to 28), and finally 2% NaCl alone (days 29 to 34). *P < 0.001 Cyp4a10–/– versus amiloride-treated Cyp4a10–/– mice. #P ≤ 0.001 Cyp4a10–/– versus Cyp4a10+/+ mice for all additional amiloride treatment regimes. **P < 0.001 Cyp4a10–/– mice on water versus Cyp4a10–/– mice on 2% salt water.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 2 patents
Referenced in 3 Wikipedia pages
Highlighted by 1 platforms
45 readers on Mendeley
See more details